1.	Multihance Versus Magnevist in Breast MRI Phase: Phase III Type: Diagnostic Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: MH 131, NCT00486473
2.	Gadobutrol Magnevist-controlled Body Study Phase: Phase III Type: Diagnostic Status: Completed Age: 20 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 13297, NCT01050829
3.	Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, NIH WGMCC Protocol IDs: 990025, 99-C-0025, CDR0000066875, NCT00019604
4.	Diagnostic Study of Computed Tomography and Magnetic Resonance Imaging in the Pretreatment Evaluation of Patients With Invasive Cervical Cancer Phase: No phase specified Type: Diagnostic Status: Completed Age: Not specified Sponsor: NCI Protocol IDs: ACRIN-6651, NCT00004936, GOG-183
5.	Pilot Diagnostic Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Children or Adults Who Receive Neurotoxic Therapy for Cancer Phase: No phase specified Type: Diagnostic Status: Closed Age: Any age Sponsor: NCI Protocol IDs: NCI-99-C-0088, NCT00020293
6.	Diagnostic Study of Contrast-Enhanced Magnetic Resonance Imaging and Correlative Molecular Studies in Women With Locally Advanced Breast Cancer Who Are Receiving Neoadjuvant Chemotherapy Phase: No phase specified Type: Diagnostic Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: CALGB-150007, NCT00033397
7.	Diagnostic Study of Contrast-Enhanced Breast Magnetic Resonance Imaging for Women With Stage III Breast Cancer Who Are Receiving Neoadjuvant Chemotherapy Phase: No phase specified Type: Diagnostic Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: ACRIN-6657, CALGB-150012, NCT00043017
8.	Diagnostic Study of Magnetic Resonance Imaging in Evaluating the Contralateral Breast of Women With a Recent Unilateral Diagnosis of Breast Cancer Phase: No phase specified Type: Diagnostic Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: ACRIN-6667, NCT00058058
9.	Diagnostic Study of Dynamic Contrast-Enhanced MRI Using the Access to Prostate Tissue Under MRI Guidance System (APT-MRI) for Prostate Cancer Delineation and Characterization in Patients With Confirmed or Suspected Adenocarcinoma of the Prostate Phase: No phase specified Type: Diagnostic Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-04-C-0171, NCT00085514